Genotypic drug-resistance prediction for MTBC is rapidly becoming more favoured than phenotypic drug-susceptibility testing due to its comparative speed and reliability 1 and has been endorsed by the ...
OXFORD, England--(BUSINESS WIRE)--Diffblue today announced the general availability of the Diffblue Testing Agent, an autonomous regression test generator that works with an enterprise’s existing AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results